Grace Therapeutics Inc. (GRCE)
NASDAQ: GRCE
· Real-Time Price · USD
3.25
0.17 (5.52%)
At close: Aug 15, 2025, 3:08 PM
Grace Therapeutics Ratios and Metrics
Financials in USD. Fiscal
year is
April - March.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 |
PE Ratio | -3.52 | 12.29 | -2.59 | -2.52 | -3.14 | -2.18 | -2.36 | -1.74 | -1.39 | -0.19 | -1.44 | -1.13 | -1.23 | -1.3 | -1.47 | 4.19 | -1.05 |
PEG Ratio | 0.01 | -0.11 | -0.13 | -0.1 | 0.11 | -0.35 | 0.09 | 0.09 | 0.02 | -0.00 | 0.07 | -0.14 | -0.24 | -0.18 | 0.00 | -0.03 | 0.02 |
PS Ratio | n/a | 3.91K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 0.74 | 0.47 | 0.83 | 0.62 | 0.55 | 0.45 | 0.35 | 0.34 | 0.35 | 0.33 | 0.23 | 0.22 | 0.21 | 0.19 | 0.20 | 0.14 | 0.24 |
P/FCF Ratio | -26.26 | -10.59 | -10.46 | -8.17 | -9.15 | -13.1 | -11.92 | -10.76 | -3.59 | -6.71 | -6.01 | -6.49 | -4.09 | -6.47 | -4.85 | -2.69 | -3.84 |
P/OCF Ratio | -26.26 | -10.59 | -10.46 | -8.17 | -9.15 | -13.24 | -11.92 | -10.76 | -3.59 | -6.73 | -6.01 | -6.5 | -4.1 | -6.47 | -4.85 | -2.69 | -3.84 |
OCF/S Ratio | n/a | -369.25 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | n/a | n/a | n/a | n/a | n/a | n/a | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
Quick Ratio | 8.87 | 11.77 | 6.06 | 6.01 | 7.86 | 14.26 | 15.19 | 20.68 | 12.01 | 8.59 | 9.74 | 9.86 | 11.13 | 13.89 | 16.91 | 12.19 | 25.75 |
Current Ratio | 8.87 | 11.77 | 6.06 | 6.01 | 7.86 | 14.26 | 15.19 | 20.68 | 12.01 | 8.59 | 9.74 | 9.86 | 11.13 | 13.89 | 16.91 | 12.19 | 25.75 |
Asset Turnover | n/a | 0.00 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -507.64 | n/a | n/a | n/a | -29.95 | n/a | n/a | n/a |
Return on Equity | -0.05 | 0.01 | -0.08 | -0.06 | -0.04 | -0.05 | -0.04 | -0.05 | -0.06 | -0.43 | -0.04 | -0.05 | -0.04 | -0.04 | -0.03 | 0.01 | -0.06 |
Return on Assets | -0.05 | 0.01 | -0.07 | -0.05 | -0.04 | -0.04 | -0.03 | -0.04 | -0.06 | -0.37 | -0.03 | -0.04 | -0.04 | -0.03 | -0.03 | 0.01 | -0.05 |
Return on Invested Capital | n/a | 0.08 | -0.05 | -0.06 | -0.06 | -0.04 | -0.04 | -0.02 | -0.06 | -0.38 | -0.03 | -0.04 | -0.04 | -0.03 | -0.04 | -0.03 | -0.05 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | 0.63 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | 79.50 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | -47.75 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | -397.88 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | -397.63 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |